BRCA1 and breast carcinoma: The first study investigating FANCC germline mutations enrolled 88 BRCA1/2-negative familial breast cancer patients from the United Kingdom, finding no deleterious mutations by conformation sensitive gel electrophoresis followed by a sequencing assay (26).